Cameron Durrant - 02 Mar 2022 Form 4 Insider Report for HUMANIGEN, INC

Role: Chief Executive Officer, Director
Signature: /s/ Henry Madrid, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 02 Mar 2022
Net transactions value: +$93,600
Form type: 4
Filing time: 04 Mar 2022, 05:06:43 UTC
Previous filing: 14 Jan 2022
Next filing: 29 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HGEN	Common Stock	Purchase	$93,600	+40,000	+133%	$2.34	70,000	02 Mar 2022	By Cameron Durrant Revocable Trust	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.295 to $2.34, inclusive. The reporting person undertakes to provide upon request to the issuer, the Securities and Exchange Commission or any security holder of the issuer full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.295 to $2.34, inclusive. The reporting person undertakes to provide upon request to the issuer, the Securities and Exchange Commission or any security holder of the issuer full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Remarks:

Exhibit List: Exhibit 24 -- Power of Attorney